NCT07277270 2026-01-07A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Recruiting84 enrolled
NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts